KELIX bio, a pan-African biopharmaceutical platform, has entered into a binding agreement to acquire Moroccan Pharmaceutical Institute (“PHI”). This investment marks KELIX bio’s first entry into Morocco – an important market in the company’s strategy – at a time when the Kingdom is accelerating the successful rollout of AMO (Assurance Maladie Obligatoire), a far-reaching plan […]
Deal & transactions
Healthcare, Pharma & Life Sciences
Other
Bayan Dental acquires majority stake in Sky Dental. The advisors
Meysan Partners advised Al Bayan Medical Company (“Bayan Dental”) in connection with its acquisition of a majority stake in Sky for the Management of Specialized Medical Centers (“Sky Dental”), a Kuwaiti dental clinic owned
Deal & transactions
Healthcare, Pharma & Life Sciences
United Arab Emirates
GluCare.Health partners with Novo Nordisk on its weight management pilot
GluCare.Health, a hybrid digital therapeutics company focused on diabetes, have signed a partnership agreement to launch a value-based weight management pilot with Danish multinational pharmaceutical company, Novo Nordisk. Set to begin in September 2022, the
Deal & transactions
Healthcare, Pharma & Life Sciences
United Arab Emirates
ADQ to acquire Turkish pharmaceuticals company Birgi Mefar Group
Turkish pharmaceuticals company Birgi Mefar Group (BMG) has entered into a definitive acquisition agreement with ADQ, an Abu Dhabi- based investment and holding company. BMG is one of Turkey’s leading producers of sterile injectable
Capital Markets
Healthcare, Pharma & Life Sciences
United Arab Emirates
Baker McKenzie advises on the sale of New You Medical
New You Medical Center, a day surgery medical and beauty center in Saudi Arabia focused on bariatric procedures, has completed the sale of a majority equity stake of 51% to Nomu-listed Arabian International Healthcare Holding Co. (“
